Viewing Study NCT02716103


Ignite Creation Date: 2025-12-24 @ 7:45 PM
Ignite Modification Date: 2026-02-24 @ 2:07 PM
Study NCT ID: NCT02716103
Status: COMPLETED
Last Update Posted: 2021-09-10
First Post: 2016-03-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment in Patients With AL Amyloidosis
Sponsor: Boston Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Amyloidosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AL amyloidosis, systemic primary amyloidosis View